Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging
Shen, Zheyu; Wu, Aiguo; Chen, Xiaoyuan
刊名MOLECULAR PHARMACEUTICS
2017
卷号14期号:5页码:1352-1364
ISSN号1543-8384
英文摘要Magnetic iron oxide nanoparticles (MIONs) have attracted enormous attention due to their wide applications, including for magnetic separation, for magnetic hyperthermia, and as contrast agents for magnetic resonance imaging (MRI). This review article introduces the methods of synthesizing MIONs, and their application as MRI contrast agents. Currently, many methods have been reported for the synthesis of MIONs. Herein, we only focus on the liquid-based synthesis methods including aqueous phase methods and organic phase methods. In addition, the MIONs larger than 10 nm can be used as negative contrast agents and the recently emerged extremely small MIONs (ES-MIONs) smaller than 5 nm are potential positive contrast agents. In this review, we focus on the ES-MIONs because ES-MIONs avoid the disadvantages of MION-based T-2- and gadolinium chelate-based T-1-weighted contrast agents.
公开日期2017-12-25
内容类型期刊论文
源URL[http://ir.nimte.ac.cn/handle/174433/13850]  
专题2017专题
推荐引用方式
GB/T 7714
Shen, Zheyu,Wu, Aiguo,Chen, Xiaoyuan. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging[J]. MOLECULAR PHARMACEUTICS,2017,14(5):1352-1364.
APA Shen, Zheyu,Wu, Aiguo,&Chen, Xiaoyuan.(2017).Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.MOLECULAR PHARMACEUTICS,14(5),1352-1364.
MLA Shen, Zheyu,et al."Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging".MOLECULAR PHARMACEUTICS 14.5(2017):1352-1364.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace